DATROWAY: payments to doctors
Payments that named DATROWAY as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $3.4M
- Providers
- 5,318
- Transactions
- 10,999
- Average per transaction
- $309
The per-transaction average — $309 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 5,318 providers the average total is $639, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Daiichi Sankyo Inc. | $1,668,746 | 49.1% |
| AstraZeneca | $1,587,531 | 46.7% |
| Astrazeneca UK Limited | $132,582 | 3.9% |
| Daiichi Sankyo Company LTD | $8,263 | 0.2% |